THE MEDICAL NEWS |
Popis: from News-Medical.Net - Latest Medical News and Research from Around the World
|
||||||
New PET imaging tracks tumor progression and cardiac inflammation during cancer therapy8:13 A novel PET imaging approach enables simultaneous visualization of tumor progression and cardiac inflammatory responses during cancer treatment. PSMA PET detects high-risk prostate cancer bone metastases7:40 Compared to conventional imaging techniques, prostate specific membrane antigen (PSMA) PET imaging provides superior detection of bone metastases in prostate cancer patients a critical indicator of a patient's long-term survival. New imaging method distinguishes inflammation from lung fibrosis7:40 A new SPECT/CT imaging approach can accurately differentiate inflammation from fibrosis in interstitial lung disease (ILD) patients, according to new research presented at the Society of Nuclear Medicine and Molecular Imaging 2026 Annual Meeting. Justicia carnea extract alleviates oxidative stress in pancreatitis7:40 Chronic pancreatitis is an inflammatory disease and is difficult to manage despite advancements in medical science. Hypoxia-gated AAV enables targeted treatment for advanced NSCLC7:40 Adeno‑associated virus (AAV) vectors offer safety and durable expression but lack tumor specificity. This hypothesis proposes an NSCLC‑directed, hypoxia‑responsive AAV platform that integrates MGS4 peptide‑guided capsid targeting with dual hypoxia‑responsive element (HRE)‑gated promoters driving Q‑CXCL9‑Fc (chemokine) and miR‑30‑based shRNA against mesothelin (MSLN). Mesenchymal drift may explain how aging cells lose their identity7:07 Mesenchymal drift may help explain how cells lose stable identity and acquire pro-fibrotic, inflammatory mesenchymal traits during aging. The review proposes MD as a unifying framework that links multiple hallmarks of aging and highlights partial reprogramming as a potential, but still preclinical, way to counteract this process. New T-cell engager therapy shows effectiveness in advanced solid tumors7:07 A team led by researchers from the National Center for Tumor Diseases (NCT/UCC) Dresden at the Carl Gustav Carus University Hospital (UKD) and the Carl Gustav Carus Faculty of Medicine at the TUD Dresden University of Technology will present clinical results for the first time on May 31, 2026, at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) regarding a new cancer immunotherapy for the treatment of advanced tumors. The right seafood choices can help diets meet health and climate goals6:34 Fish can support healthy and sustainable diets, especially when it replaces red and processed meat rather than adding to overall animal-food intake. However, its environmental value depends on species, production system, supply chain, local dietary patterns, and the scale of greenhouse gas reductions required. Higher-dose ocrelizumab depletes more B cells but does not slow MS progression4:55 Higher-dose ocrelizumab produced greater peripheral B-cell depletion than the approved 600 mg regimen in two phase 3b trials of relapsing and primary progressive multiple sclerosis. However, the higher doses did not significantly delay disability progression, supporting the 600 mg dose as the current standard regimen with a favorable benefit-risk profile. Novel PRRT approach shows promise in advanced neuroendocrine tumors4:55 A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who have exhausted conventional treatment options. |
Noviny
Sépie
Černé
Konzole
Modré
Přihlásit
Založit účet
Souhrn
Moje
Home
World
Sport
Economy
Technology
Culture
Life & Style
Other